JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT03557970 · TERMINATED
Trial details
- NCT number
- NCT03557970
- Sponsor
- OHSU Knight Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-05
- Primary completion
- 2020-09-28
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.